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The effects of balloon aortic valvuloplasty on orifice variability of 
the stenotic sclerocalcific aortic valve were evaluated by hemody· 
namic measurements of aortic valve function in 14 patients before 
balloon aortic valvuloplasty, during nitroprusside infusion before 
valvuloplasty, 48 h after valvuloplasty and during nitroprusside 
infusion 48 h after valvuloplasty. Aortic valve function was 
assessed by aortic valve area calculations with use of the Gorlin 
and Cannon formulas. 
Nitroprusside infusion before balloon aortic valvuloplasty 
caused no change in mean aortic valve gradient but a significant 
increase in mean aortic transvalvular flow from 186 ± 46 to 202 ± 
61 mIls (p < 0.05), in Gorlin aortic valve area from 0.49 ± 0.17 to 
0.53 ± 0.21 cm2 (p < 0.05) and in Cannon aortic valve area from 
0.45 ± 0.18 to 0.49 ± 0.22 cm2 (p < 0.05). Nitroprusside infusion 
48 h after valvuloplasty induced no change in mean aortic valve 
gradient but a significant increase in mean aortic transvalvular 
Assessment of the severity of valvular stenosis by orifice 
area calculations 0,2) is based on the concept of a fixed 
orifice valve. In aortic stenosis, this concept presumes that 
the aortic valve orifice is strictly determined by valve 
anatomy and remains fixed irrespective of the magnitude of 
transvalvular pressure gradient or flow. Recent studies (3) 
challenged this concept and reported changes in effective 
valve orifice size with increasing transvalvular flow. When 
left ventricular stroke volume was increased during exercise 
(4) or by reducing prematurity of extrasystolic beats (5), a 
larger calculated aortic valve area or wider opening of the 
aortic valve leaflets was observed. From these observations 
orifice variability of the stenotic aortic valve appears to 
result from a variable impact of left ventricular ejection on 
the opening motion of the rigid aortic valve leaflets. Slower 
ejection decreases the initial kinetic energy that can be 
transferred to "set" the rigid valve leaflets and reduces 
effective valve orifice. 
In the present study we evaluated orifice variability of the 
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flow from 214 ± 61 to 254 ± 78 mIls (p < 0.005), in Gorlin aortic 
valve area from 0.71 ± 0.25 to 0.83 ± 0.32 cm2 (p < 0.01) and in 
Cannon aortic valve area from 0.78 ± 0.33 to 0.88 ± 0.40 cm2 
(p < 0.05). Forty·eight hours after valvuloplasty, nitroprusside 
infusion induced a larger increase (40 ± 40 mIls) in mean 
transvalvular flow than before valvuloplasty (16 ± 27 mIls; p < 
0.05) and a larger increase (0.12 ± 0.14 cm2) in Gorlin aortic 
valve area than before valvuloplasty (0.05 ± 0.07 cm2; p < 0.05). 
Balloon aortic valvuloplasty, which causes splitting of fused 
commissures and fracturing of calcific deposits within the valve 
leaflets, reduces the inertia of the leaflets during their opening 
motion. This explains the larger increment after balloon aortic 
valvuloplasty of effective valve orifice, when transvalvular flow is 
increased during nitroprusside infusion. 
() Am Coll CardioI1991;17:1263-9) 
stenotic aortic valve before and 48 h after balloon aortic 
valvuloplasty by repeating aortic valve area measurements 
during infusion of nitroprusside. As evident from postmor-
tem and intraoperative balloon dilations (6-8), balloon aortic 
valvuloplasty enlarges the stenotic valve orifice by opening 
fused commissures and by fracturing calcified nodules within 
the valve leaflets. The splitting of commissures and fractur-
ing of calcific deposits not only enlarges the valve orifice but 
also reduces the inertia of the valve leaflets during their 
opening motion. These effects could shift the relation be-
tween effective valve orifice and the impact of left ventricu-
lar ejection. Balloon aortic valvuloplasty therefore provides 
an opportunity to study orifice variability of the sclerocal-
cific aortic valve at two disparate levels of valve inertia. 
Methods 
Study patients (Table 1). Fourteen patients (11 women 
and 3 men; age range 75 to 85 years [mean: 79.4]) with 
sc1erocalcific aortic stenosis were studied before and 48 h 
after balloon aortic valvuloplasty. Balloon aortic valvulo-
plasty was performed because of the estimated high surgical 
risk of aortic valve replacement as a result of advanced 
patient age or concomitant debilitating noncardiac disease. 
Predominant symptoms were dyspnea (n = 9), angina (n = 
11) and syncope or presyncope with exertion (n = 3). Eight 
0735-1097/91/$3.50 
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Table 1. Clinical Characteristics of 14 Patients 
Age (yr)1 LVEDVI LVEF LVMI 
Patient Gender (mllm2) (%) (g/m2) 
771M 57 85 165 
2 751F 40 74 211 
79/F 39 42 131 
4 84/F 54 66 100 
5 79/F 64 69 93 
6 751F 
7 751F 68 55 152 
8 751F 
9 82/F 93 41 219 
\0 851M 
11 851F 
12 771M 98 59 214 
13 83/F 114 58 253 
14 80/F 
Mean 791 70 61 171 
±SD 41 26 14 57 
F = feminine; L VEDVI = left ventricular end-diastolic volume index; 
L VEF = left ventricular ejection fraction; L VMI = left ventricular mass 
index; M = masculine. 
patients were in New York Heart Association functional 
class III and six were in functional class IV (Table I; Patients 
1,4,6,7,11 and 13). No patient had more than trivial aortic, 
mitral or tricuspid regurgitation on a baseline Doppler 
echocardiogram or left ventricular contrast angiogram or 
contrast aortogram, and no patient had significant coronary 
artery stenosis (luminal diameter narrowing >50%) on a 
coronary arteriogram. 
Table 1 lists individual patient characteristics (age, gen-
der) for all 14 patients and left ventricular function data of 
the 9 patients in whom a left ventricular contrast angiogram 
was obtained. All patients had sinus rhythm at the time of 
balloon aortic valvuloplasty and at the time of repeat cath-
eterization 48 h later. No patient had significant pulsus 
alternans. At the time of both studies, six patients were 
taking digoxin and no patient was taking any other positive 
or negative inotropic drug. There were no immediate com-
plications as a result of valvuloplasty or repeat catheteriza-
tion 48 h later except for an arterial pseudoaneurysm at the 
right femoral artery balloon entry site in Patients 12 and 13. 
All studies were performed in accordance with a previously 
published protocol (9) that was approved by an institutional 
review board. Informed consent was obtained from each 
patient for balloon aortic valvuloplasty and repeat hemody-
namic measurements. 
Hemodynamic studies. Before balloon aortic valvulo-
plasty, diagnostic left and right heart catheterization and 
angiography were performed from a femoral approach using 
the left and right femoral arteries and left femoral vein. After 
baseline pre valvuloplasty hemodynamic measurements were 
obtained, a nitroprusside infusion was started at a rate of 
0.5 JLg/kg per min. The infusion rate was increased by 
0.5 JLg/kg per min every 3 min until mean aortic pressure had 
decreased by 20 to 30 mm Hg from baseline measurements 
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before valvuloplasty. Repeat hemodynamic measurements 
were then performed. After cessation of the nitroprusside 
infusion and return of mean aortic pressure to baseline 
value, the left ventricular catheter was exchanged for a 
0.038 in. (0.097 cm) exchange guide wire and a balloon 
dilation catheter (20 or 23 mm, Mansfield). 
Fifteen minutes after balloon dilation of the aortic valve, 
repeat hemodynamic measurements were obtained. Residual 
depression of left ventricular function shortly after balloon 
dilation (9-12) invalidates hemodynamic measurements ob-
tained at this instant. Left and right heart catheterization was 
therefore repeated 48 h after aortic valvuloplasty when left 
ventricular function was restored. After hemodynamic mea-
surements, nitroprusside was infused at ihe dose used in the 
study before valvuloplasty. At the maximal nitroprusside 
infusion rate, a final set of hemodynamic measurements was 
obtained. All pressures were referenced to atmospheric 
pressure at the level of the mid chest. Left ventricular and 
proximal aortic pressures were measured with a high fidelity 
micromanometer-tip catheter calibrated externally against a 
mercury reference and matched against luminal pressure. 
Femoral artery sheath side-arm pressure was used instead of 
proximal aortic pressure in eight patients (Patients 1 to 5 and 
7 to 9) in whom a second arterial catheter could not be 
introduced into the contralateral femoral artery at the time of 
repeat catheterization because of a groin hematoma that had 
formed after removal of the valvuloplasty balloon. 
When aortic transvalvular gradient was measured from 
femoral artery sheath side-arm pressure rather than from 
proximal aortic pressure, the mean proximal aortic pressure 
recorded from the high fidelity micro manometer-tip catheter 
before entry into the left ventricle was always superimpos-
able on the mean femoral artery pressure recorded from the 
side arm of the arterial sheath. This excluded a pressure drop 
between the proximal aorta and the femoral artery because 
of peripheral vascular disease. The pressure signals and a 
bipolar standard lead of the electrocardiogram were re-
corded on a Gould ES 1000 multichannel recorder and 
digitized on-line with a Hewlett-Packard 9836 computer (13). 
Simultaneous with each hemodynamic data collection (Ta-
bles 2 and 3), cardiac output was measured with thermodi-
lution technique (average of at least three values, 9520A 
Cardiac Output Computer, Edwards Laboratories) and arte-
riovenous oxygen content difference was determined from 
femoral and pulmonary artery oxygen saturation samples. 
Data analysis. In nine patients angiographic left ventric-
ular function indexes (Table I) were derived from a single 
plane 30° right anterior oblique left ventricular angiogram 
(14). Left ventricular wall thickness was measured on an 
end-diastolic frame two thirds of the distance from the aortic 
valve to the apex (14). Left ventricular pressure overload 
hypertrophy was evident from the increased left ventricular 
wall mass index (171 ± 57 g/m2). For each patient, aortic 
valve gradients were averaged over a complete respiratory 
cycle. Mean transvalvular aortic pressure gradient was de-
rived from planimetry of simultaneous high speed left ven-
JACC Vol. 17. No.6 
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Table 2. Hemodynamic Effects of Nitroprusside Before and After Aortic Valvuloplasty in 14 Patients 
Patient C 
LVPSP 
(mm Hg) 
Nit C 
Mean AoP 
(mmHg) 
Nit C 
Grad 
(mmHg) 
Nit C 
co 
Oiters/min) 
Nit C 
RR 
(ms) 
Nit C 
SEP 
(ms) 
Nit 
Before Balloon Aortic Valvuloplasty 
I 
2 
3 
4 
5 
6 
7 
8 
9 
10 
II 
12 
13 
14 
Mean 
±SD 
220 
260 
267 
270 
256 
175 
238 
203 
224 
236 
237 
204 
244 
254 
235 
27 
195 
263 
234 
255 
190 
129 
187 
181 
187 
225 
185 
156 
210 
180 
198* 
36 
53 
95 
98 
89 
109 
80 
101 
77 
86 
98 
75 
65 
74 
104 
86 
16 
47 
86 
80 
73 
59 
49 
55 
54 
50 
81 
58 
43 
49 
50 
59* 
14 
91 
96 
89 
94 
73 
44 
68 
61 
74 
78 
88 
83 
93 
79 
79 
15 
92 
102 
94 
102 
77 
43 
70 
72 
79 
83 
67 
67 
86 
67 
79 
16 
4.6 
5.0 
3.7 
3.7 
5.8 
5.4 
5.5 
4.8 
4.3 
4.0 
2.8 
3.9 
3.5 
5.1 
4.4 
0.9 
6.2 
5.7 
3.5 
3.9 
6.1 
5.1 
5.4 
4.8 
4.7 
5.2 
2.6 
4.1 
3.1 
4.4 
4.6 
1.1 
910 
646 
765 
800 
825 
865 
873 
888 
702 
903 
911 
1297 
731 
872 
856 
152 
802 
650 
762 
836 
738 
870 
840 
774 
664 
780 
660 
960 
780 
931 
789t 
95 
334 
308 
397 
361 
358 
294 
351 
364 
325 
354 
340 
353 
289 
346 
341 
29 
295 
317 
368 
359 
287 
238 
335 
309 
3\3 
317 
284 
297 
278 
289 
306* 
33 
48 h After Balloon Aortic Valvuloplasty 
2 
3 
4 
5 
6 
7 
8 
9 
10 
II 
12 
13 
14 
Mean 
±SD 
211 
228 
232 
203 
236 
151 
247 
165 
190 
207 
232 
206 
186 
244 
209 
29 
198 
189 
180 
156 
192 
124 
201 
121 
143 
184 
170 
152 
166 
174 
168* 
26 
81 
\14 
107 
87 
104 
76 
120 
80 
95 
94 
89 
85 
64 
102 
93 
16 
63 
82 
75 
59 
68 
51 
86 
42 
61 
77 
54 
45 
51 
54 
62* 
14 
53 
37 
45 
50 
59 
33 
48 
24 
36 
52 
71 
60 
52 
68 
49 
13 
65 
45 
45 
42 
62 
31 
52 
34 
41 
54 
57 
59 
50 
60 
50 
II 
4.8 
4.9 
4.2 
3.5 
6.2 
6.8 
4.9 
4.0 
5.7 
4.8 
2.6 
4.7 
4.2 
5.8 
4.8 
1.1 
5.3 
5.6 
4.6 
4.4 
6.4 
6.6 
7.2 
4.2 
7.8 
5.6 
2.6 
5.4 
3.8 
4.9 
5.3t 
1.4 
736 
696 
648 
814 
842 
824 
797 
909 
609 
892 
889 
1210 
720 
850 
817 
146 
636 
652 
589 
766 
729 
813 
731 
865 
574 
829 
860 
1003 
734 
807 
756* 
119 
326 
303 
294 
297 
328 
256 
317 
356 
258 
314 
305 
339 
248 
336 
306 
33 
280 
278 
235 
282 
257 
213 
272 
331 
212 
280 
243 
294 
249 
270 
264' 
32 
*p < 0.0 I versus control before or after valvuloplasty; tp < 0.05 versus control before or after valvuloplasty. AoP = aortic pressure (mm Hg); C = control 
before or after valvuloplasty; CO = cardiac output (liters/min); Grad = mean transvalvular gradient (mm Hg): LVPSP = left ventricular peak systolic pressure 
(mm Hg); Nit = during nitroprusside infusion before or after valvuloplasty; RR = RR interval (ms); SEP = systolic ejection period (ms). 
tricular and aortic or arterial pressure recordings. When 
femoral artery pressure was substituted for proximal aortic 
pressure, planimetry was performed after realignment of the 
femoral artery pressure to correct for pressure transmission 
delay. Aortic valve area was calculated using the Gorlin 
formula (valve area = flow/kY grad) or the Cannon formula 
(valve area = flow/(k' grad) + h) (1,2), whereby flow = mean 
transvalvular flow (mils), grad = mean transvalvular gradi-
ent (mm Hg), k = Gorlin formula constant = 44.3, k' and h = 
Cannon formula constants = 6.84 and 0.08. All data were 
reported as mean values ± SD. Statistical significance was 
set at p < 0.05 and was obtained for multiple comparisons by 
a multivariate analysis of variance (MANOY A) test of paired 
data and for single comparisons by Student's t test of paired 
data. 
Results 
Hemodynamic effects of nitroprusside before and 48 h after 
balloon aortic valvuloplasty (Table 2). Nitroprusside infusion 
in the 14 patients before and 48 h after balloon aortic 
valvuloplasty caused similar and significant reductions in left 
ventricular peak systolic pressure, mean aortic pressure, RR 
interval and systolic ejection period. Only 48 h after balloon 
aortic valvuloplasty did nitroprusside infusion cause a sig-
nificant increase in cardiac output. Nitroprusside infusion 
caused a comparable decrease in systemic vascular resis-
tance before valvuloplasty (from 1,522 dynes's'cm-5 to 
1,017 dynes's'cm-5, p < 0.001) and 48 h after valvuloplasty 
(from 1,554 dynes's'cm- 5 to 944 dynes's'cm- 5 , p < 0.001). 
Mean trans valvular gradient remained unaltered during ni-
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Table 3. Effects of Balloon Aortic Valvuloplasty on Valve Orifice 
Variability in 14 Patients 
Before V 
After V 
Before V 
After V 
Before V 
After V 
Before V 
After V 
Before Nit 
Mean Transvalvular Gradient (mm Hg) 
79 ± 15 
49 ± 13* 
A = 0.7 ± 10 
A = 0.6 ± 7 
Mean Transvalvular Flow (mIls) 
A = 16 ± 27 
During Nit 
79 ± 16 
50 ± 11* 
186 ± 46 202 ± 61t 
214 ± 62* 254 ± 78*t 
A=40±40* 
GorIin Aortic Valve Area (cm2) 
0.49 ± 0.17 
0.71 ± 0.25* 
A = 0.05 ± 0.07 
A = 0.12 ± 0.14* 
Cannon Aortic Valve Area (cm2) 
A = 0.04 ± 0.07 
0.53 ± 0.21t 
0.83 ± 0.32*t 
0.45 ± 0.18 0.49 ± 0.22t 
0.78 ± 0.33* 0.88 ± 0.40*t 
A = 0.10 ± 0.16 
*P < 0.05 vs. before valvuloplasty; tp < 0.05 versus before nitroprusside 
infusion. Nit = nitroprusside infusion; V = balloon aortic valvuloplasty. 
troprusside infusion both before and 48 h after valvuloplasty. 
Figure 1 shows a representative set of left ventricular and 
aortic pressure recordings obtained before valvuloplasty, 
during nitroprusside infusion before valvuloplasty, 48 h after 
valvuloplasty and during nitroprusside infusion 48 h after 
valvuloplasty. 
Figure 1. Patient 10. Recordings of left ventricular (Iv) and aortic 
(ao) pressures before balloon aortic valvuloplasty (A), during nitro-
prusside infusion before valvuloplasty (B), 48 h after valvuloplasty 
(C) and during nitroprusside infusion 48 h after valvuloplasty (D). 
pressure 
mmHg 
100 
A 
Iv 
ao 
B c o 
..J 
\. 
o ~ ________________________________ __ 
1 sec 
aGrad (mm Hg) aFlow (milS) 
100 -.------~ 
10 
o .ll.-_...J.J 
16.27 40.40 
0.2 
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Figure 2. Bar graph showing changes in mean aortic transvalvular 
gradient (~Grad), in mean transvalvular flow (~Flow) and in Gorlin 
aortic valve area (~A V A) during nitroprusside infusion before (open 
bars) and 48 h after (hatched bars) balloon aortic valvuloplasty. *p < 
0.05. 
Effects of balloon aortic valvuloplasty on valve orifice 
variability. Table 3 compares mean aortic transvalvular 
gradient, mean aortic transvalvular flow, aortic valve area 
calculated by Gorlin formula and aortic valve area calculated 
by Cannon formula before balloon aortic valvuloplasty, 
during nitroprusside infusion before valvuloplasty, 48 h after 
valvuloplasty and during nitroprusside infusion 48 h after 
valvuloplasty. Mean aortic transvalvular gradient remained 
unaltered during nitroprusside infusion both before and 48 h 
after valvuloplasty (Fig. 2). Forty-eight hours after valvulo-
plasty, the increase in mean transvalvular flow (40 :±: 40 mlls) 
was larger than before valvuloplasty (16 :±: 27 mlls; p < 0.05). 
Similarly, the increase in Gorlin aortic valve area observed 
during nitroprusside infusion 48 h after valvuloplasty (0.12 :±: 
0.14 cm2) was larger than the increase observed before 
valvuloplasty (0.05 :±: 0.07 cm2, p < 0.05). 
A separate statistical analysis was performed on the 
subgroup of six patients (Patients 6 and 10 to 14), in whom 
mean aortic trans valvular gradient was derived from a high 
fidelity tip-micro manometer left ventricular pressure signal 
and a high fidelity tip-micro manometer proximal aortic pres-
sure signal. All patients in whom a fluid-filled femoral artery 
sheath side-arm pressure was used to measure mean aortic 
transvalvular gradient were excluded from this analysis. 
Statistical results in this subgroup were identical to the 
overall study results: 1) a significant increase was observed 
48 h after balloon aortic valvuloplasty in Gorlin aortic valve 
area at rest (0.77 :±: 0.37 vs. 0.52 :±: 0.22 cm2, p < 0.01) 
and during nitroprusside infusion (0.87 :±: 0.44 vs. 0.58 ± 
0.28 cm2, p < 0.01); 2) Gorlin aortic valve area increased 
significantly (p < 0.05) during nitroprusside infusion both 
before and after valvuloplasty. 
Discussion 
Orifice variability of the stenotic aortic valve. Severity of 
valvular stenosis has been assessed by valve area calcula-
tions using mathematic formulas relating transvalvular gra-
JACC Vol. 17. No.6 
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dient to transvalvular flow. The classic formula for calculat-
ing valve area was first introduced by Gorlin and Gorlin 0): 
Valve area = Flow/kYGradient, where k = an empirically 
determined constant. The use of this formula has been 
challenged on both theoretic and physiologic grounds. 
In vitro experiments on porcine bioprostheses using a 
pulsatile flow model found the Gorlin formula constant (k) to 
be dependent on the square root of the mean trans valvular 
gradient (2). Hence, a new formula was proposed by Cannon 
et al. (2) for calculating valve area: Valve area = Flowl 
(k'Gradient) + h, where k' and h are sets of constants that 
differ widely if the formula is applied to bioprosthetic valves 
or to native mitral stenosis. From these studies, it appears 
that the severity of valvular stenosis can also be assessed in 
terms of valvular conductance (quotient of transvalvular 
flow and pressure) or valvular resistance (quotient of trans-
valvular pressure and flow) 05,16) and that each stenotic 
valve requires a proper set of constants to correctly relate its 
valvular conductance to its anatomic valve area. These 
concepts were countered by a recent in vitro study (7) that 
showed no appreciable change of the orifice discharge coef-
ficient with transvalvular flow. 
Clinical studies in which Gorlin aortic valve area mea-
surements were repeated during exercise (4) or after postex-
trasystolic potentiation (5) failed to yield identical valve 
areas. The larger Gorlin aortic valve areas calculated at 
higher output states observed during exercise or after post-
extrasystolic potentiation could be explained by the depen-
dence of the Gorlin formula constant k on the magnitude of 
the transvalvular gradient. A larger transvalvular gradient 
observed at a higher output state would necessitate the use 
of a larger constant k to correctly calculate aortic valve area. 
Failure to do so could explain the observed increase of 
Gorlin aortic valve area at the higher output state. The 
observed increase of aortic valve area at a higher output 
state could also be a true physiologic phenomenon and not 
just an artifact caused by an incorrect Gorlin formula con-
stant. 
Determinants of effective valve orifice. Effective valve 
orifice could indeed be partially dependent on the degree of 
leaflet opening caused by the impact of the bloodstream and 
not exclusively determined by valve architecture. With use 
of an in vitro pulsatile flow model (2), orifice variability of a 
normal porcine valve and of a severely stenotic porcine 
valve (valve area = 0.3 cm2) was directly measured by 
planimetry of videotaped images of the valve orifice obtained 
at different trans valvular flows. For a normal porcine valve, 
orifice variability was negligible for trans valvular flow rang-
ing from 150 to 500 mlls and a significant decrease in orifice 
area was observed only at flows lower than the physiologic 
range. When valve leaflets become stiff and calcified as 
occurs in senile sclerocalcific degeneration of the aortic 
valve, the amount of kinetic energy required to achieve 
maximal leaflet opening is larger and a significant decrease in 
orifice area could therefore occur at transvalvular flows 
within the physiologic range. When valve leaflets become 
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fused as in severe aortic stenosis, leaflet excursion remains 
greatly reduced irrespective of the amount of kinetic energy 
transferred to the leaflets during ejection. This again leads to 
a reduction of orifice variability, which was indeed directly 
observed on videotaped images of a severely stenotic por-
cine valve (2) and of stenotic human aortic valves (8). For 
a severely stenotic porcine valve, orifice variability was 
<0.05 cm2 for trans valvular flow ranging from 50 to 200 mlls 
and for the stenotic human aortic valve, valve area was 
essentially fixed at clinically observed flow rates. 
The ideal pathologic substrate for valve orifice variability 
would therefore consist of a valve whose leaflets are stiff in 
the absence of commissural fusion. Such conditions occur 
after successful aortic valvuloplasty for senile sclerocalcific 
aortic stenosis. Balloon aortic valvuloplasty opens fused 
valve commissures and fractures calcific nodules within the 
valve leaflets. The leaflets themselves, however, remain stiff 
because of the presence of calcified deposits (6-8). In the 
present study, we therefore investigated the effects of bal-
loon aortic valvuloplasty on orifice variability of the stenotic 
aortic valve. 
Effects of aortic valvuloplasty on orifice variability. In the 
present study, orifice variability of the stenotic aortic valve 
was assessed by repeating aortic valve area measurements 
during nitroprusside infusion administered at equal doses 
before and 48 h after balloon aortic valvuloplasty. During 
nitroprusside infusion, the mean transvalvular gradient re-
mained unaltered but mean transvalvular flow increased 
significantly both before and 48 h after aortic valvuloplasty. 
Aortic valve area calculated by the Gorlin and Cannon 
formulas followed a similar trend. The increase in Gorlin 
aortic valve area during nitroprusside infusion before aortic 
valvuloplasty is small (0.04 cm2) and comparable with the 
previously reported orifice variability of stenotic bioprosthe-
ses (0.05 cm2) mounted in an vitro pulsatile flow model (2). 
Commissural fusion could explain the small orifice variabil-
ity of the native stenotic sclerocalcific aortic valve before 
aortic valvuloplasty. Forty-eight hours after valvuloplasty a 
significantly larger increase in mean transvalvular flow and 
in Gorlin aortic valve area (0.12 cm2) was observed during 
nitroprusside infusion. Both splitting of fused commissures 
and fracture of calcific nodules could have contributed to the 
larger orifice variability by reducing the inertia of the valve 
leaflets during their opening motion. 
Methodologic critiques. In the present study, a repeat 
hemodynamic evaluation was performed 48 h after balloon 
aortic valvuloplasty at a time when the depressant effect of 
the valvuloplasty balloon inflations had worn off. Valvulo-
plasty balloon inflations cause transient episodes of hypo-
tension and reduced coronary perfusion leading to myocar-
dial ischemia (9-12). Reduced left ventricular performance 
caused by residual myocardial ischemia shortly after valvu-
loplasty could invalidate an immediate hemodynamic evalu-
ation after valvuloplasty. We therefore preferred to perform 
postvalvuloplasty hemodynamic measurements at the time 
of a repeat study 48 h after valvuloplasty. 
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Transvalvular gradients. These were obtained by 
planimetry from a high fidelity tip-micro manometer left 
ventricular pressure signal in all 14 patients, a second high 
fidelity tip-micromanometer proximal aortic pressure signal 
in 6 patients and a femoral artery pressure signal derived 
from a fluid-filled side arm of an arterial sheath in 8 patients. 
In the subset of six patients in whom transvalvular aortic 
gradients were derived from proximal aortic pressure re-
cordings, statistical analysis of the data yielded a trend 
similar to that of the overall group. When measuring trans-
valvular gradients, substitution of femoral artery pressure 
for proximal aortic pressure can introduce some errors of 
gradient measurement (19). In these patients in whom a 
fluid-filled arterial sheath side arm was used, mean proximal 
aortic pressure and mean femoral artery pressure were 
always superimposable, thereby excluding a significant pres-
sure drop between the proximal aorta and femoral artery 
because of peripheral vascular disease. In these patients, 
planimetry of transvalvular gradients was performed after 
realignment of the peripheral artery pressure recording to 
correct for pressure transmission delay. Realignment can 
lead to underestimation of the trans valvular gradient and 
overestimation of the calculated aortic valve area. However, 
this error is especially small in the range of significant aortic 
stenosis «0.8 cm2) and most of the errors occur in valve 
areas> 1.0 cm2 (19). In the present study, even the largest 
average Gorlin aortic valve area (0.83 ± 0.32 cm2), which 
was observed during nitroprusside infusion after balloon 
aortic valvuloplasty, still fell within the range of valve areas 
for which errors related to peripheral pressure realignment 
are small. Moreover, underestimation of the transvalvular 
gradient because of peripheral pressure realignment remains 
similar before and after nitroprusside infusion and its effect 
is therefore canceled when performing a pairwise compari-
son of gradients to assess valve orifice variability. 
Cardiac output. This variable was determined by ther-
modilution technique. Except for low output states «2 
liters/min per m2) and significant tricuspid regurgitation, the 
accuracy of the thermodilution technique is comparable with 
that of the Fick method (20-22). In the present study, I 
(Patient II) of the 14 patients had a baseline cardiac index of 
<2 liters/min per m2 (1.9 liters/min per m2) and no patient 
had more than trace tricuspid regurgitation on baseline 
Doppler echocardiographic examination. Sequential aortic 
transvalvular flow calculations based on thermodilution car-
diac output values could also be offset by variable degrees of 
aortic regurgitation after aortic valvuloplasty or during vaso-
dilator infusion. In the present study, however, both before 
and 48 h after aortic valvuloplasty, no patient had > I + 
aortic regurgitation either on Doppler echocardiography or 
on contrast aortography. This observation excludes major 
variations in the degree of aortic regurgitation as a confound-
ing factor for the sequential aortic transvalvular flow calcu-
lations. 
Transvalvular gradient versus flow. In the present study, 
nitroprusside infusion before and 48 h after balloon aortic 
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valvuloplasty left the mean trans valvular aortic pressure 
gradient unchanged and significantly increased mean trans-
valvular aortic flow. In contrast, both variables were signif-
icantly increased by supine leg exercise (4) or dobutamine 
infusion (23) in previous studies of orifice variability of the 
stenotic aortic valve. Because of the increase in mean 
transvalvular aortic pressure gradient, the calculated in-
crease in Gorlin aortic valve area observed in the previous 
studies becomes dependent on the mathematic validity of the 
Gorlin formula. If the Gorlin formula constant k is not 
constant but dependent on the magnitude of the gradient (2), 
the calculated increase in Gorlin aortic valve area could be 
explained by a mathematic error introduced through im-
proper use of the Gorlin formula constant. In the present 
study, nitroprusside infusion caused a smaller increase in 
mean trans valvular aortic flow than that previously observed 
during exercise or dobutamine infusion but, because it left 
mean aortic transvalvular gradient unaltered, the calculated 
increase in Gorlin aortic valve area remained correct irre-
spective of the validity of the Gorlin formula constant. 
Orifice variability of the stenotic aortic valve and the origin 
of symptoms in aortic stenosis. The discriminant role of 
symptoms on prognosis in severe aortic stenosis is evident 
from earlier retrospective postmortem reviews (24) of aortic 
stenosis and recent prospective studies (25) on the outcome 
of symptomatic and asymptomatic patients with valvular 
aortic stenosis. Factors other than attaining a critical aortic 
valve area or a critical trans valvular gradient appear to be 
responsible for the origin of angina, dyspnea or syncope in 
patients with severe aortic stenosis. Myocardial alterations 
frequently related to the presence of left ventricular hyper-
trophy have received major attention as a cause of symp-
toms in patients with aortic stenosis. Both impaired coro-
nary vasodilation of hypertrophied myocardium (26) and 
depressed myocardial oxygen supply/demand ratio (12,27) 
cause left ventricular ischemia during hemodynamic stress 
and have been proposed as mechanisms for angina in pa-
tients with aortic stenosis. Inappropriately high wall stress 
caused by failure of compensatory left ventricular hypertro-
phy (28) and reduced left ventricular compliance of the 
hypertrophied left ventricle (29) could lead to cardiac failure 
either at rest or during exertion. Inadequate augmentation of 
cardiac output, altered baroreceptor sensitivity or arryth-
mogenic properties of hypertrophied myocardium could 
each contribute to exercise-induced syncope (30,31). 
Role of orifice variability in symptom reduction. Charac-
teristics of the stenotic aortic valve other than valve area or 
transvalvular gradient have never been investigated as 
causes of symptoms in severe aortic stenosis. In the present 
study orifice variability of the stenotic aortic valve was 
evaluated in patients with severe aortic stenosis referred for 
balloon aortic valvuloplasty because of refractory symptoms 
and high surgical risk. During administration of vasodilators 
before valvuloplasty, the valve orifice showed only a mini-
mal increase (0.05 cm2). Forty-eight hours after valvulo-
plasty, a larger increase (0.12 cm2) in orifice size of the aortic 
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valve was observed during a similar administration of the 
same vasodilator drug. After valvuloplasty, the relative 
increase in orifice variability (140%) exceeds the relative 
decrease in transvalvular gradient (38%) or the relative 
increase in aortic valve area (45%), both of which remain 
within the range of severe aortic stenosis (32). Although the 
effects of aortic valvuloplasty on orifice variability cannot be 
separated from the effects on trans valvular gradient or aortic 
valve area, restored orifice variability could playa role in the 
symptomatic improvement after aortic valvuloplasty (33,34). 
After valvuloplasty, an additional enlargement of the effec-
tive valve orifice during a hyperdynamic state like exercise 
would permit an additional increase in cardiac output. This 
higher cardiac output could help to maintain adequate cere-
bral and coronary perfusion during exercise-induced vasodi-
lation, thus preventing the occurrence of syncope or angina. 
Conclusions. Orifice variability of the stenotic aortic 
valve was determined by repeating aortic valve area mea-
surements during nitroprusside infusion at equal doses be-
fore and 48 h after balloon aortic valvuloplasty. During 
nitroprusside infusion, the mean transvalvular pressure gra-
dient remained unaltered both before and 48 h after valvu-
loplasty. The increase in mean transvalvular flow and in 
Gorlin aortic valve area during nitroprusside infusion was 
larger 48 h after valvuloplasty. Opening of fused commis-
sures explains the larger orifice variability of the sclerocal-
cific aortic valve after balloon aortic valvuloplasty. 
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